AG
HAE icon

Algert Global’s Haemonetics HAE Stock Holding History

Algert Global’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.39M Buy
77,840
+870
+1% +$56.7K 0.07% 476
2025
Q4 		$6.17M Buy
+76,970
New +$5.17M 0.1% 358
2025
Q3 		– Sell
-30,520
Closed -$2.28M – 1216
2025
Q2 		$2.28M Buy
+30,520
New +$2.02M 0.05% 590
2024
Q3 		– Sell
-22,972
Closed -$1.9M – 1347
2024
Q2 		$1.9M Sell
22,972
-30,945
-57% -$2.72M 0.06% 481
2024
Q1 		$4.6M Buy
53,917
+32,390
+150% +$2.54M 0.18% 174
2023
Q4 		$1.84M Sell
21,527
-3,310
-13% -$286K 0.07% 440
2023
Q3 		$2.23M Buy
24,837
+12,690
+104% +$1.13M 0.1% 331
2023
Q2 		$1.03M Sell
12,147
-25,732
-68% -$2.18M 0.05% 650
2023
Q1 		$3.13M Buy
+37,879
New +$3.07M 0.15% 206
2022
Q4 		– Sell
-11,524
Closed -$853K – 1186
2022
Q3 		$853K Sell
11,524
-2,063
-15% -$148K 0.05% 607
2022
Q2 		$886K Sell
13,587
-910
-6% -$53.9K 0.07% 531
2022
Q1 		$917K Buy
14,497
+668
+5% +$36.3K 0.06% 561
2021
Q4 		$733K Buy
13,829
+1,700
+14% +$104K 0.09% 384
2021
Q3 		$856K Buy
+12,129
New +$765K 0.11% 311

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Algert Global's HAE Position: Q1 2026 in Review

Algert Global increased its Haemonetics (HAE) stake by 1.1% in Q1 2026, buying an estimated $56.7K and bringing the position to 77,840 shares worth $4.39M. The position accounts for 0.07% of the portfolio, ranked #476.

Algert Global first reported a position in HAE in Q3 2021 and has held it in 14 quarters since. The position peaked at $6.17M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Algert Global held 77,840 shares of Haemonetics worth $4.39M as of Q1 2026.
  • Algert Global bought 870 Haemonetics shares in Q1 2026, an estimated $56.7K.
  • Haemonetics made up 0.07% of Algert Global's portfolio in Q1 2026, its #476 holding.
  • Algert Global first reported a position in Haemonetics in Q3 2021 and has held it in 14 quarters since.
  • Algert Global's Haemonetics position peaked at $6.17M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.